Showing results (11-20 of 229) with videos related to
Sort By:
Pageof 23
Journal of Immunology (Baltimore, Md. : 1950)|January 1, 1996
Activation of NK cells by CC chemokines. Chemotaxis, Ca2+ mobilization, and enzyme releaseP Loetscher, M Seitz, I Clark-Lewis, et al.The Journal of Biological Chemistry|August 26, 1998
N-terminal peptides of stromal cell-derived factor-1 with CXC chemokine receptor 4 agonist and antagonist activitiesP Loetscher, J H Gong, B Dewald, et al.Journal of Immunology (Baltimore, Md. : 1950)|February 15, 1994
Production of interleukin-1 receptor antagonist, inflammatory chemotactic proteins, and prostaglandin E by rheumatoid and osteoarthritic synoviocytes--regulation by IFN-gamma and IL-4M Seitz, P Loetscher, B Dewald, et al.European Journal of Immunology|April 1, 1995
Interleukin-10 differentially regulates cytokine inhibitor and chemokine release from blood mononuclear cells and fibroblastsM Seitz, P Loetscher, B Dewald, et al.FEBS Letters|May 19, 1997
CKbeta8, a novel CC chemokine that predominantly acts on monocytesU Forssmann, M B Delgado, M Uguccioni, et al.The Journal of Experimental Medicine|June 16, 1997
Eotaxin-2, a novel CC chemokine that is selective for the chemokine receptor CCR3, and acts like eotaxin on human eosinophil and basophil leukocytesU Forssmann, M Uguccioni, P Loetscher, et al.The American Journal of Pathology|August 1, 1996
Monocyte chemoattractant protein-1 gene expression in prostatic hyperplasia and prostate adenocarcinomaL Mazzucchelli, P Loetscher, A Kappeler, et al.European Journal of Immunology|March 10, 2001
Rapid inactivation of stromal cell-derived factor-1 by cathepsin G associated with lymphocytesM B Delgado, I Clark-Lewis, P Loetscher, et al.British Journal of Rheumatology|July 1, 1995
Methotrexate action in rheumatoid arthritis: stimulation of cytokine inhibitor and inhibition of chemokine production by peripheral blood mononuclear cellsM Seitz, P Loetscher, B Dewald, et al.The Journal of Biological Chemistry|December 9, 2000
The ligands of CXC chemokine receptor 3, I-TAC, Mig, and IP10, are natural antagonists for CCR3P Loetscher, A Pellegrino, J H Gong, et al.Pageof 23